Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,438 | 84,260 | 75,916 | 109,997 | 99,044 |
| Marketable Securities | 350,391 | 401,521 | 473,764 | 499,586 | 349,008 |
| Receivables | N/A | 19,000 | N/A | N/A | N/A |
| TOTAL | $440,603 | $515,330 | $563,703 | $619,387 | $456,043 |
| Non-Current Assets | |||||
| PPE Net | 20,498 | 18,773 | 18,449 | 17,757 | 17,069 |
| Investments And Advances | 0 | 0 | 0 | 0 | 9,472 |
| Other Non-Current Assets | 61,371 | 57,452 | 32,891 | 32,199 | 31,016 |
| TOTAL | $81,869 | $76,225 | $51,340 | $49,956 | $57,557 |
| Total Assets | $522,472 | $591,555 | $615,043 | $669,343 | $513,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,609 | 5,954 | 8,397 | 11,482 | 3,918 |
| Accrued Expenses | 43,957 | 37,005 | 44,361 | 37,994 | 27,828 |
| TOTAL | $82,350 | $75,614 | $89,988 | $95,854 | $86,296 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 25,993 | 27,420 | 30,591 | 38,364 | 47,997 |
| Other Non-Current Liabilities | 52,695 | 46,696 | 19,984 | 20,289 | 20,590 |
| TOTAL | $67,870 | $68,338 | $44,138 | $46,496 | $50,448 |
| Total Liabilities | $150,220 | $143,952 | $134,126 | $142,350 | $136,744 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,883 | 76,449 | 76,236 | 75,887 | 70,836 |
| Common Shares | 77 | 76 | 76 | 76 | 67 |
| Retained earnings | -925,005 | -838,584 | -795,120 | -738,769 | -680,220 |
| Other shareholders' equity | 119 | -20 | 226 | 150 | 344 |
| TOTAL | $372,252 | $447,603 | $480,917 | $526,993 | $376,856 |
| Total Liabilities And Equity | $522,472 | $591,555 | $615,043 | $669,343 | $513,600 |